Tiprenolol
Tiprenolol[edit]
Tiprenolol is a non-selective beta-adrenergic receptor antagonist used in the management of various cardiovascular conditions. As a member of the beta-blocker class of medications, Tiprenolol functions by inhibiting the action of endogenous catecholamines, such as epinephrine and norepinephrine, on beta-adrenergic receptors.
Pharmacology[edit]
Tiprenolol exhibits its effects primarily through competitive antagonism of beta-1 and beta-2 adrenergic receptors. This action results in decreased heart rate, myocardial contractility, and cardiac output, which are beneficial in conditions such as hypertension, angina pectoris, and certain types of arrhythmias.
Mechanism of Action[edit]
The primary mechanism of action of Tiprenolol involves the blockade of beta-adrenergic receptors located in the heart and vascular smooth muscle. By preventing the binding of catecholamines to these receptors, Tiprenolol reduces the sympathetic nervous system's influence on the cardiovascular system, leading to a decrease in heart rate and blood pressure.
Pharmacokinetics[edit]
Tiprenolol is absorbed from the gastrointestinal tract and undergoes hepatic metabolism. The drug is excreted primarily via the kidneys. The pharmacokinetic profile of Tiprenolol may vary based on individual patient factors, including liver and kidney function.
Clinical Uses[edit]
Tiprenolol is indicated for the treatment of several cardiovascular disorders:
- Hypertension: By reducing cardiac output and inhibiting renin release, Tiprenolol helps lower blood pressure.
- Angina Pectoris: The reduction in myocardial oxygen demand makes Tiprenolol effective in managing angina symptoms.
- Arrhythmias: Tiprenolol can be used to control heart rate in various arrhythmias, including atrial fibrillation and ventricular tachycardia.
Side Effects[edit]
Common side effects of Tiprenolol include bradycardia, hypotension, fatigue, and dizziness. As with other beta-blockers, caution is advised in patients with asthma or chronic obstructive pulmonary disease (COPD) due to potential bronchoconstriction.
Contraindications[edit]
Tiprenolol is contraindicated in patients with:
- Severe bradycardia
- Heart block greater than first degree
- Cardiogenic shock
- Overt cardiac failure
Related pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
